Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Bionano Genomics, Inc. (BNGO)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-Q | 8-K | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 73.4% | 72.1% | 78.0% | 77.9% | 84.9% | 96.2% | 75.2% | 62.7% |
| Gross profit | 26.6% | 27.9% | 22.0% | 22.1% | 15.1% | 3.8% | 24.8% | 37.3% |
| Selling, general and administrative | 311.0% | 350.3% | 308.2% | 326.6% | 356.0% | | 329.3% | 358.6% |
| Research and development | 168.7% | 188.0% | 170.6% | 176.4% | 184.8% | 146.2% | 139.7% | 106.0% |
| General and administrative | | | | | | 314.3% | | |
| EBITDA | -414.9% | -467.3% | -456.8% | -447.0% | -486.9% | -427.2% | -432.9% | -413.9% |
| Depreciation | 38.1% | 43.0% | | 34.0% | 38.8% | 29.5% | 11.3% | 13.4% |
| EBIT | -453.0% | -510.4% | -456.8% | -480.9% | -525.7% | -456.7% | -444.2% | -427.3% |
| Pre-tax income | -448.8% | -500.3% | -448.8% | -481.5% | -525.7% | -455.7% | -445.1% | -487.0% |
| Income taxes | 0.4% | 0.4% | 22.0% | 0.6% | 0.2% | -91.5% | 0.8% | 0.2% |
| Net income | -449.2% | -500.7% | -470.8% | -482.1% | -525.8% | -364.2% | -445.8% | -487.2% |
|